These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
171 related articles for article (PubMed ID: 8391387)
1. Overexpression of urokinase receptor increases matrix invasion without altering cell migration in a human osteosarcoma cell line. Karikó K; Kuo A; Boyd D; Okada SS; Cines DB; Barnathan ES Cancer Res; 1993 Jul; 53(13):3109-17. PubMed ID: 8391387 [TBL] [Abstract][Full Text] [Related]
2. Inhibition of urokinase receptor gene expression and cell invasion by anti-uPAR DNAzymes in osteosarcoma cells. de Bock CE; Lin Z; Itoh T; Morris D; Murrell G; Wang Y FEBS J; 2005 Jul; 272(14):3572-82. PubMed ID: 16008557 [TBL] [Abstract][Full Text] [Related]
3. In vitro inhibition of human glioblastoma cell line invasiveness by antisense uPA receptor. Mohanam S; Chintala SK; Go Y; Bhattacharya A; Venkaiah B; Boyd D; Gokaslan ZL; Sawaya R; Rao JS Oncogene; 1997 Mar; 14(11):1351-9. PubMed ID: 9178895 [TBL] [Abstract][Full Text] [Related]
4. EGF-stimulated migration in ovarian cancer cells is associated with decreased internalization, increased surface expression, and increased shedding of the urokinase plasminogen activator receptor. Henic E; Sixt M; Hansson S; Høyer-Hansen G; Casslén B Gynecol Oncol; 2006 Apr; 101(1):28-39. PubMed ID: 16263158 [TBL] [Abstract][Full Text] [Related]
5. Targeting of urokinase plasminogen activator receptor in human pancreatic carcinoma cells inhibits c-Met- and insulin-like growth factor-I receptor-mediated migration and invasion and orthotopic tumor growth in mice. Bauer TW; Liu W; Fan F; Camp ER; Yang A; Somcio RJ; Bucana CD; Callahan J; Parry GC; Evans DB; Boyd DD; Mazar AP; Ellis LM Cancer Res; 2005 Sep; 65(17):7775-81. PubMed ID: 16140945 [TBL] [Abstract][Full Text] [Related]
6. Role of urokinase plasminogen activator receptor in thrombospondin 1-mediated tumor cell invasion. Albo D; Berger DH; Rothman VL; Tuszynski GP J Surg Res; 1999 Apr; 82(2):331-8. PubMed ID: 10090848 [TBL] [Abstract][Full Text] [Related]
7. Binding of urokinase to its receptor promotes migration and invasion of human melanoma cells in vitro. Stahl A; Mueller BM Cancer Res; 1994 Jun; 54(11):3066-71. PubMed ID: 8187097 [TBL] [Abstract][Full Text] [Related]
8. Inhibitory effects of antisense cathepsin B cDNA transfection on invasion and motility in a human osteosarcoma cell line. Krueger S; Haeckel C; Buehling F; Roessner A Cancer Res; 1999 Dec; 59(23):6010-4. PubMed ID: 10606250 [TBL] [Abstract][Full Text] [Related]
9. A urokinase receptor mRNA binding protein-mRNA interaction regulates receptor expression and function in human pleural mesothelioma cells. Shetty S; Idell S Arch Biochem Biophys; 1998 Aug; 356(2):265-79. PubMed ID: 9705217 [TBL] [Abstract][Full Text] [Related]
10. DU145 human prostate carcinoma invasiveness is modulated by urokinase receptor (uPAR) downstream of epidermal growth factor receptor (EGFR) signaling. Mamoune A; Kassis J; Kharait S; Kloeker S; Manos E; Jones DA; Wells A Exp Cell Res; 2004 Sep; 299(1):91-100. PubMed ID: 15302576 [TBL] [Abstract][Full Text] [Related]
11. Thrombospondin-1 up-regulates tumor cell invasion through the urokinase plasminogen activator receptor in head and neck cancer cells. Albo D; Tuszynski GP J Surg Res; 2004 Jul; 120(1):21-6. PubMed ID: 15172186 [TBL] [Abstract][Full Text] [Related]
12. Structure, function and expression on blood and bone marrow cells of the urokinase-type plasminogen activator receptor, uPAR. Plesner T; Behrendt N; Ploug M Stem Cells; 1997; 15(6):398-408. PubMed ID: 9402652 [TBL] [Abstract][Full Text] [Related]
13. The urokinase-system in tumor tissue stroma of the breast and breast cancer cell invasion. Hildenbrand R; Schaaf A Int J Oncol; 2009 Jan; 34(1):15-23. PubMed ID: 19082473 [TBL] [Abstract][Full Text] [Related]
14. Synergistic down-regulation of urokinase plasminogen activator receptor and matrix metalloproteinase-9 in SNB19 glioblastoma cells efficiently inhibits glioma cell invasion, angiogenesis, and tumor growth. Lakka SS; Gondi CS; Yanamandra N; Dinh DH; Olivero WC; Gujrati M; Rao JS Cancer Res; 2003 May; 63(10):2454-61. PubMed ID: 12750266 [TBL] [Abstract][Full Text] [Related]
15. uPA and uPAR contribute to NK cell invasion through the extracellular matrix. Al-Atrash G; Kitson RP; Xue Y; Mazar AP; Kim MH; Goldfarb RH Anticancer Res; 2001; 21(3B):1697-704. PubMed ID: 11497249 [TBL] [Abstract][Full Text] [Related]
16. Receptor-mediated regulation of plasminogen activator function: plasminogen activation by two directly membrane-anchored forms of urokinase. Vines DJ; Lee SW; Dichek DA; Ellis V J Pept Sci; 2000 Sep; 6(9):432-9. PubMed ID: 11016879 [TBL] [Abstract][Full Text] [Related]
17. Modulation of invasive properties of human glioblastoma cells stably expressing amino-terminal fragment of urokinase-type plasminogen activator. Mohanam S; Chandrasekar N; Yanamandra N; Khawar S; Mirza F; Dinh DH; Olivero WC; Rao JS Oncogene; 2002 Nov; 21(51):7824-30. PubMed ID: 12420219 [TBL] [Abstract][Full Text] [Related]
18. Heregulin regulation of urokinase plasminogen activator and its receptor: human breast epithelial cell invasion. Mazumdar A; Adam L; Boyd D; Kumar R Cancer Res; 2001 Jan; 61(1):400-5. PubMed ID: 11196194 [TBL] [Abstract][Full Text] [Related]
19. Enhanced expression of urokinase receptor induced through the tissue factor-factor VIIa pathway in human pancreatic cancer. Taniguchi T; Kakkar AK; Tuddenham EG; Williamson RC; Lemoine NR Cancer Res; 1998 Oct; 58(19):4461-7. PubMed ID: 9766679 [TBL] [Abstract][Full Text] [Related]
20. Inhibition of epidermal growth factor-induced invasion by dexamethasone and AP-1 decoy in human squamous cell carcinoma cell lines. Shiratsuchi T; Ishibashi H; Shirasuna K J Cell Physiol; 2002 Dec; 193(3):340-8. PubMed ID: 12384986 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]